Skip to main content
SpringerLink
Log in

Pharmaka zur Behandlung von Funktionsstörungen des endokrinen Systems

  • Chapter
Pharmakologie und Toxikologie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 853 Accesses

Zusammenfassung

Der wichtigste Weg für die Zell-zu-Zell-Kommunikation des Organismus verläuft über die Synthese von chemischen Botenstoffen, die in bestimmten Zellen synthetisiert und sezerniert werden und ihre Botschaft dann an andere Zellen weitergeben. Dies ist der Weg, über den die klassischen Hormone, Gewebshormone, Wachstumsfaktoren und Neurotransmitter wirken.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Agarwal MK, Mirshahi M (1999) General overview of mineralocorticoid hormone action. Pharmacol Ther 84:273–326

    Article  PubMed  CAS  Google Scholar 

  • Baird DT, Glasier AF (1993) Hormonal contraception. N Engl J Med 328:1543–1549

    Article  PubMed  CAS  Google Scholar 

  • Baron JA, Sandler RS (2000) Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 51:511–523

    Article  PubMed  CAS  Google Scholar 

  • Baumgarten HG, Göthert M (eds) (1997) Serotoninergic neurons and 5-HT receptors in the CNS. In: Handbook of experimental pharmacology, vol 129. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Belchetz PE (1994) Hormonal treatment of postmenopausal women. N Engl J Med 330:1062–1071

    Article  PubMed  CAS  Google Scholar 

  • Bell GI, Reisine T (1993) Molecular biology of somatostatin receptors. Trends Neurosci 16:34–38

    Article  PubMed  CAS  Google Scholar 

  • Berenson JR, Lipton A (1999) Bisphosphonates in the treatment of malignant bone disease. Annu Rev Med 50:237–248

    Article  PubMed  CAS  Google Scholar 

  • Bergkvist L, Adami H-O, Persson I, Hoover R, Schairer C (1989) The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293–297

    Article  PubMed  CAS  Google Scholar 

  • Bhoola KD, Figueroa CD, Worthy K (1992) Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol Rev 44:1–80

    PubMed  CAS  Google Scholar 

  • Boess FG, Martin IL (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33:275–317

    Article  PubMed  CAS  Google Scholar 

  • Brash AR (1999) Liposygenases: Occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 274:23679–23689

    Article  PubMed  CAS  Google Scholar 

  • Brent GA (1994) The molecular basis of thyroid hormone action. N Engl J Med 331:847–853

    Article  PubMed  CAS  Google Scholar 

  • Brogden RN, Goa KL, Faulds D (1993) Mifepristone: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 45:348–409

    Article  Google Scholar 

  • Brune K, Hinz B (1998) Zum aktuellen Stand der Zyklooxygenase-Forschung. Dtsch Ärztebl 95:C271–273

    Google Scholar 

  • Cadepond F, Ulmann A, Baulieu EE (1997) RU486 (mifepristone): Mechanisms of action and clinical uses. Annu Rev Med 48:129–156

    Article  PubMed  CAS  Google Scholar 

  • Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351–1362

    Article  PubMed  CAS  Google Scholar 

  • Conn PM, Crowley WF (1991) Gonadotropin-releasing hormone and its analogs. Annu Rev Med 45:391–405

    Article  Google Scholar 

  • Cooper DS (1984) Antithyroid drugs. N Engl J Med 311:1353–1362

    Article  PubMed  CAS  Google Scholar 

  • Cronstein BN, Weissmann G (1995) Targets for antiinflammatory drugs. Annu Rev Pharmacol Toxicol 35:449–462

    Article  PubMed  CAS  Google Scholar 

  • Dray A, Perkins M (1993) Bradykinin and inflammatory pain. Trends Neurosci 16:99–104

    Article  PubMed  CAS  Google Scholar 

  • Drazen JM, Israel E, O’Byrne PM (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197–206

    Article  PubMed  CAS  Google Scholar 

  • Drife JO, Baird DT (eds) (1993) Contraception. Br Med Bull Vol 49/1, Churchill Livingstone, Edingburgh

    Google Scholar 

  • Eastell R (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338:736–746

    Article  PubMed  CAS  Google Scholar 

  • Farmer SG, Burch RM (1992) Biochemical and molecular pharmacology of kinin receptors. Annu Rev Pharmacol Toxicol 32:511–536

    Article  PubMed  CAS  Google Scholar 

  • Flower RJ, Rothwell NJ (1994) Lipocortin-1: Cellular mechanisms and clinical relevance. Trends Pharmacol Sci 15:71–76

    Article  PubMed  CAS  Google Scholar 

  • Franklyn JA (1994) The management of hyperthyroidism. N Engl J Med 330:1731–1738

    Article  PubMed  CAS  Google Scholar 

  • Frey BM, Frey FJ (1990) Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 19:126–146

    Article  PubMed  CAS  Google Scholar 

  • Funder JW (1993) Aldosterone action. Annu Rev Physiol 55:115–130

    Article  PubMed  CAS  Google Scholar 

  • Funder JW (1997) Glucocorticoid and mineralocorticoid receptors: Biology and clinical relevance. Annu Rev Med 48:231–240

    Article  PubMed  CAS  Google Scholar 

  • Gittoes NJ, Franklyn JA (1998) Hyperthyroidism. Current treatment guidelines. Drugs 55:543–553

    Article  PubMed  CAS  Google Scholar 

  • Glass CK, Rose DW, Rosenfeld MG (1997) Nuclear receptor coactivators. Curr Opin Cell Biol 9:222–232

    Article  PubMed  CAS  Google Scholar 

  • Goodfried TL, Elliot ME, Catt KJ (1996) Angiotensin receptors and their antagonists. N Engl J Med 334:1649–1654

    Article  Google Scholar 

  • Griffin JE, Ojeda SR (eds) (1996) Textbook of endocrine physiology, 3rd ed. Oxford Univ Press, New York Oxford

    Google Scholar 

  • Hall JM (1997) Bradykinin receptors. Gen Pharmacol 28:1–6

    Article  PubMed  CAS  Google Scholar 

  • Helfer EL, Rose LI (1989) Corticosteroids and adrenal suppression: Characterising and avoiding the problem. Drugs 38:838–845

    Article  PubMed  CAS  Google Scholar 

  • Heller A, Koch T, Schmeck J, van Ackern K (1998) Lipid mediators in inflammatory disorders. Drugs 55:487–496

    Article  PubMed  CAS  Google Scholar 

  • Hesch RD (Hrsg) (1989) Endokrinologie Teil A: Grundlagen. In: Gerok W, Hartmann F, Schuster H-P (Hrsg) Innere Medizin der Gegenwart, Bd 4. Urban & Schwarzenberg, München Wien Baltimore

    Google Scholar 

  • Hesch RD (Hrsg) (1989) Endokrinologie TeilB: Krankheitsbilder. In: Gerok W, Hartmann F, Schuster H-P (Hrsg) Innere Medizin der Gegenwart. Bb 5. Urban & Schwarzenberg, München Wien Baltimore

    Google Scholar 

  • Humphrey PPA, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14:233–236

    Article  PubMed  CAS  Google Scholar 

  • Kam PC, See AU (2000) Cyclo-oxygenase isoenzymes: Physiological and pharmacological role. Anaesthesia 55:442–449

    Article  PubMed  CAS  Google Scholar 

  • Kaunitz AM, Rosenfield A (1993) Injectable contraception with depot medroxyprogesterone acetat: Current status. Drugs 45:857–865

    Article  PubMed  CAS  Google Scholar 

  • Khaw KT (ed) (1992) Hormone replacement therapy. Br Med Bull Vol 48/2, Churchill divingstone, Edinburgh

    Google Scholar 

  • Leff JA et al. (1998) Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchocontriction. N Engl J Med 339:147–152

    Article  PubMed  CAS  Google Scholar 

  • Leurs R, Blandina P, Tedford C, Timmerman H (1998) Therapeutic potential of histamine H3-receptor agonists and antagonists. Trends Pharmacol Sci 19:177–183

    Article  PubMed  CAS  Google Scholar 

  • Liscovitch M, Cantley LC (1994) Lipid second messengers. Cell 77:329–334

    Article  PubMed  CAS  Google Scholar 

  • Liu C, Ma XJ, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg TW (2001) Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59:420–426

    PubMed  CAS  Google Scholar 

  • Lucas PC, Granner DK (1992) Hormone response domains in gene transcription. Annu Rev Biochem 61:1131–1173

    Article  PubMed  CAS  Google Scholar 

  • Lukas SE (1993) Current perspectives on anabolic-androgenic steroid abuse. Trends Pharmacol Sci 14:61–68

    Article  PubMed  CAS  Google Scholar 

  • Markham A, Wagstaff AJ (1998) Fexofenadine. Drugs 55:269–274

    Article  PubMed  CAS  Google Scholar 

  • Martin GR, Humphrey PPA (1994) Receptors for 5-hydroxytryptamine: Current perspectives on classification and nomenclature. Neuropharmacology 33:261–273

    Article  PubMed  CAS  Google Scholar 

  • Marx J (1995) How the glucocorticoids suppress immunity. Science 270:232–233

    Article  PubMed  CAS  Google Scholar 

  • McEwen BS (1991) Non-genomic and genomic effects of steroids on neuronal activity. Trends Pharmacol Sci 12:141–147

    Article  PubMed  CAS  Google Scholar 

  • Meyers FH, Jawetz E, Goldfien A (1975): Lehrbuch der Pharmakologie. Springer, Berlin, Heidelberg, New York

    Book  Google Scholar 

  • Mitlak BH, Cohen FJ (1999) Selective estrogen receptor modulators. Drugs 57:653–663

    Article  PubMed  CAS  Google Scholar 

  • Mundy GR, Yoneda T (1998) Bisphosphonates as anticancer drugs. N Engl J Med 339:398–400

    Article  PubMed  CAS  Google Scholar 

  • Musser JH, Kreft AF (1992) 5-Lipoxygenase: Properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors. J Med Chem 35:2501–2524

    Article  PubMed  CAS  Google Scholar 

  • Neely EK, Rosenfeld RG (1994) Use and abuse of human growth hormone. Annu Rev Med 45:407–420

    Article  PubMed  CAS  Google Scholar 

  • Oettel M, Schillinger E (eds) (1999) Estrogens and antiestrogens I and II. In: Handbook of experimental pharmacology, vol 135/1 and 135/2. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Paschke R, Ludgate M (1997) The thyrotropin receptor in thyroid diseases. N Engl J Med 337:1675–1681

    Article  PubMed  CAS  Google Scholar 

  • Petersen OH, Petersen CCH, Kasai H (1994) Calcium and hormone action. Annu Rev Physiol 56:297–319

    Article  PubMed  CAS  Google Scholar 

  • Power RF, Conneely OM, O’Malley BW (1992) New insights into activation of the steroid hormone receptor super-family. Trends Pharmacol Sci 13:318–323

    Article  PubMed  CAS  Google Scholar 

  • Pratt WB (1997) The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu Rev Pharmacol Toxicol 37:297–326

    Article  PubMed  CAS  Google Scholar 

  • Raiteri M (1994) Functional studies of neurotransmitter receptors in human brain. Life Sci 54:1635–1647

    Article  PubMed  CAS  Google Scholar 

  • Raynal P, Pollard HB (1994) Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Bio- phys Acta 1197:63–93

    Article  CAS  Google Scholar 

  • Reinwein D, Röher H-D, Emrich D (1993) Therapie der Hyperthyreose: Aktueller Stand. Dtsch Med Wochenschr 118:1036–1043

    Article  PubMed  CAS  Google Scholar 

  • Reznek RH, Armstrong P (1994) The adrenal gland. Clin Endocrinol 40:561–576

    Article  CAS  Google Scholar 

  • Rodan GA (1998) Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol 38:375–388

    Article  PubMed  CAS  Google Scholar 

  • Sautebin L, Carnuccio R, Ialenti A, Di Rosa M (1992) Lipocor- tin and vasocortin: Two species of anti-inflammatory proteins mimicking the effects of glucocorticoids. Pharmcol Res 25:1–12

    Article  CAS  Google Scholar 

  • Schneider WE (1978): Ovar. In: Labhardt A: Klinik der inneren Sekretion. Springer, Berlin, Heidelberg, New York. 523–686

    Google Scholar 

  • Shimizu T, Honda Z, Nakamura M, Bito H, Izumi T (1992) Platelet-activating factor receptor and signal transduction. Biochem Pharmacol 44:1001–1008

    Article  PubMed  CAS  Google Scholar 

  • Simons FER, Simons KJ (1994) The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med 330: 1663–1670

    Article  PubMed  CAS  Google Scholar 

  • Slater JW, Zechnich AD, Haxby DG (1999) Second-generation antihistamines: A comparative review. Drugs 57:31–47

    Article  PubMed  CAS  Google Scholar 

  • Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem 69:145–182

    Article  PubMed  CAS  Google Scholar 

  • Spitz IM, Croxatto HB, Robbins A (1996) Antiprogestins: Mechanism of action and contraceptive potential. Annu Rev Pharmacol Toxicol 36:47–81

    Article  PubMed  CAS  Google Scholar 

  • Strauss RH, Yesalis CE (1991) Anabolic steroids in the athlete. Annu Rev Med 42:449–457

    Article  PubMed  CAS  Google Scholar 

  • Strobl JS, Thomas MJ (1994) Human growth hormone. Pharmacol Rev 46:1–34

    PubMed  CAS  Google Scholar 

  • Tata JR (1967): Ribosomes and thyroid hormones. In: Karlson P (Hrsg.): Wirkungsmechanismen der Hormone. Spinger, Berlin, Heidelberg, New York, 87–103

    Chapter  Google Scholar 

  • Toft AD (1994) Thyroxine therapy. N Engl J Med 331:174–180

    Article  PubMed  CAS  Google Scholar 

  • Turnbull AV, Rivier CL (1999) Regulation of the hypothala- mic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 79:2–43

    Google Scholar 

  • Ur E, Grossman A (1992) Corticotropin-releasing hormone in health and disease: An update. Acta Endocrinol 127:193–199

    PubMed  CAS  Google Scholar 

  • Vance ML (1994) Hypopituitarism. N Engl J Med 330: 1651–1662

    Article  PubMed  CAS  Google Scholar 

  • Wehling M, Christ M, Gerzer R (1993) Aldosterone-specific membrane receptors and related rapid, non-genomic effects. Trends Pharmacol Sci 14:1–4

    Article  PubMed  CAS  Google Scholar 

  • Weiss RE, Refetoff S (1992) Thyroid hormone resistance. Annu Rev Med 43:363–375

    Article  PubMed  CAS  Google Scholar 

  • Weetman AP, Grossman A (eds) (1997) Pharmacotherapeu- tics of the thyroid gland. In: Handbook of experimental pharmacology, vol 128. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Wehling M (1997) Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 59:365–393

    Article  PubMed  CAS  Google Scholar 

  • White PC (1994) Disorders of aldosterone biosysthesis and action. N Engl J Med 331:250–258

    Article  PubMed  CAS  Google Scholar 

  • Wilckens T (1995) Glucocorticoids and immune function: Physiological relevance and the pathogenic potential of hormonal dysfunction. Trends Pharmacol Sci 16:193–197

    Article  PubMed  CAS  Google Scholar 

  • Wilde MI, Goa KL (1999) Finasteride. An update of its use in the management of symptomatic benign prostatic hyperplasia. Drugs 57:557–581

    Article  PubMed  CAS  Google Scholar 

  • Winkler M, Rath W (1999) Anwendungsbereiche von RU 486 in Gynäkologie und Geburtshilfe. Dtsch Ärztebl 96: C1437–1442

    Google Scholar 

  • Woodruff TK, Mather JP (1995) Inhibin, activin and the female reproductive axis. Annu Rev Physiol 57:219–244

    Article  PubMed  CAS  Google Scholar 

  • Yen PM, Chin WW (1994) New advances in understanding the molecular mechanisms of thyroid hormone action. Trends Endocrinol Metabol 5:65–72

    Article  CAS  Google Scholar 

  • Zhang J, Lazar MA (2000) The mechanism of action of thyroid hormones. Annu Rev Physiol 62:439–466

    Article  PubMed  CAS  Google Scholar 

  • Zifa E, Fillion G (1992) 5-Hydroxytryptamine receptors. Pharmacol Rev 44:401–458

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Oberdisse
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Fachbereich Humanmedizin — Institut für Pharmakologie, Freie Universität Berlin, Thielallee 67-73, 14195, Berlin, Germany

    Eckard Oberdisse

  2. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany

    Eberhard Hackenthal

  3. Institut für Pharmakologie und Toxikologie, Universität Marburg/Lahn, Ketzerbach 63, 35032, Marburg, Germany

    Klaus Kuschinsky

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Oberdisse, E. (2002). Pharmaka zur Behandlung von Funktionsstörungen des endokrinen Systems. In: Oberdisse, E., Hackenthal, E., Kuschinsky, K. (eds) Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56314-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56314-0_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62634-0

  • Online ISBN: 978-3-642-56314-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation